Information Provided By:
Fly News Breaks for November 6, 2019
SUPN
Nov 6, 2019 | 04:55 EDT
Jefferies analyst David Steinberg downgraded Supernus Pharmaceuticals to Hold from Buy with a $23 price target.
News For SUPN From the Last 2 Days
There are no results for your query SUPN